Genomics

Dataset Information

0

LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients


ABSTRACT: The international, multicenter registry LOGGIC Core BioClinical Data Bank aims to enhance the understanding of tumor biology in pediatric low-grade glioma (pLGG) and provide clinical and molecular data to support treatment decisions and interventional trial participation. Hence, the question arises whether implementation of RNA sequencing (RNA-Seq) using Fresh Frozen (FrFr) tumor tissue in addition to gene panel and DNA methylation analysis improves diagnostic accuracy and provides additional clinical benefit. RNA-Seq was performed on 125 of the samples for which FrFr tumor tissue was available. We confirmed KIAA1549::BRAF-fusion (n=71), BRAF V600E-mutation (n=12) and alterations in FGFR1 (n=14) as the most frequent alterations, among other common molecular drivers (n=12). . N=16 cases (13%) presented rare gene fusions (e.g. TPM3::NTRK1, EWSR1::VGLL1, SH3PXD2A::HTRA1, PDGFB::LRP1, GOPC::ROS1). In n=27 cases (22%), RNA-Seq detected a driver alteration not otherwise identified (22/27 actionable). The rate of driver alteration detection was hereby increased from 75% to 97%. Furthermore, FGFR1 ITD (n=6) were only detected by RNA-Seq using current bioinformatics pipelines, leading to a change in analysis protocols.

PROVIDER: EGAS00001007072 | EGA |

REPOSITORIES: EGA

Similar Datasets

2020-12-08 | GSE161944 | GEO
2023-02-22 | PXD034229 | JPOST Repository
2015-07-01 | E-GEOD-48953 | biostudies-arrayexpress
2011-03-04 | E-GEOD-27659 | biostudies-arrayexpress
2012-03-01 | E-GEOD-34824 | biostudies-arrayexpress
2020-08-11 | PXD015231 | Pride
2020-08-27 | GSE142442 | GEO
2020-02-26 | GSE142441 | GEO
2015-07-01 | GSE48953 | GEO
| phs001854 | dbGaP